{"database": "openregs", "table": "dockets", "rows": [["FDA-2003-P-0348", "FDA", "make a determination that a Hydrocodone Bitartrate and Acetaminophen Tablet, USP 5 mg/300 mg combination drug product is suitable for submissin as an ANDA-CLOSED", "Nonrulemaking", "2021-09-01T01:03:11Z", "0b00006480496f76"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2003-P-0348"], "units": {}, "query_ms": 0.39368285797536373, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}